The Peptide Pricing Report: What 800+ Clinics Actually Charge in 2026
Every clinic owner guesses at pricing. We measured it instead. HealingMaps analyzed advertised prices across 803 peptide clinic websites in July 2026. The result is the first national benchmark for what clinics actually charge.
The headline finding is convergence. The market has quietly settled near $299 a month for GLP-1 care. But the middle of the market spans a two times range, so identical programs sell for very different prices.
Running a clinic is expensive. The Healing Health Alliance makes it cheaper. HealingMaps’ GPO, built to leverage the power of independent clinics, gets members 40 percent or more off medical supplies, 10 percent or more off malpractice coverage, discounted LegitScript certification, and 20 to 30 percent off HIPAA compliant payment processing. Joining is free with no obligation.
Click here to see what your clinic qualifies for →
Key Takeaways
| Question | What the Data Shows |
|---|---|
| What does semaglutide cost? | Median advertised price is $299 a month across 65 clinics |
| What about tirzepatide? | Median $300 a month across 54 clinics |
| Where is the widest spread? | NAD+, from $129 to $499 depending on how it is sold |
| How many prices did we capture? | 2,905 advertised prices across 803 clinic websites |
| Should I match the median? | Below the 25th percentile signals discount positioning |
HealingMaps Intelligence
Turn these benchmarks into new revenue.
The 2026 Peptide & GLP-1 Clinic Intelligence Report shows you exactly where your prices sit (percentile bands for 17 compounds), which menu gaps and add-on services add recurring revenue, and how top clinics capture more patients — including why half of all inquiries arrive after hours. Built from 846 verified clinic menus, 2,905 advertised prices, and 807 clinic websites.
Get the full report — $299 →One-time purchase · Lifetime access · Access code emailed within 2 hours
The Pricing Convergence
Compounded semaglutide medians $299 a month. Tirzepatide medians $300. Those two numbers anchor the weight management side of the industry. The table below shows the low, middle and high band for each major compound. The low is the 25th percentile. The high is the 75th percentile.
| Compound | Clinics | Low (25th) | Median | High (75th) |
|---|---|---|---|---|
| Semaglutide | 65 | $199 | $299 | $415 |
| Tirzepatide | 54 | $199 | $300 | $450 |
| NAD+ | 63 | $129 | $225 | $499 |
| Sermorelin | 28 | $200 | $290 | $300 |
| BPC-157 | 21 | $199 | $250 | $350 |
| Ipamorelin | 19 | $199 | $250 | $400 |
| GHK-Cu | 18 | $125 | $240 | $320 |
| CJC-1295 | 16 | $240 | $285 | $400 |
| PT-141 | 14 | $99 | $220 | $250 |
| Tesamorelin | 13 | $199 | $230 | $290 |
| TB-500 | 10 | $220 | $299 | $400 |
How to Read These Numbers
These are advertised prices, pulled from public clinic websites. Clinics price in different units. Some quote a monthly program, some a single vial, some a multi month package. So treat these as directional market bands, not exact per unit equivalents. Each figure counts a clinic once, using the middle of its own listed prices. We only report compounds with at least a handful of clinics behind them.
What to Do With This
Price below the 25th percentile and you signal discount telehealth. That attracts price shoppers who churn fast. It also starts a race you cannot win against national script mills. The stronger move is to hold the median and add what a mail order competitor cannot ship. Think in person body composition, lab review, injection training and provider access.
Transparency itself is an edge here. Because only about a quarter of clinics publish any price, the ones that do capture the comparison shopper. For the full picture of what clinics offer and where the menu gaps sit, see our report on the state of peptide medicine in America. The pricing pressure on compounded GLP-1s also ties directly to the FDA’s rules on human drug compounding, which continue to evolve.
